GlobeNewswire

Altimmune Announces First Quarter 2026 Financial Results and Business Update
13/05/2026
Initiation of PERFORMA Phase 3 MASH trial planned for second half 2026 $535 million in cash, cash equivalents and short-term investments as of April 30, 2026 Webcast to be held today at 8:30 a.m. ET GAITHERSBURG, Md., [...]
MediPharm Labs Reports First Quarter 2026 Results Achieving Positive Adjusted EBITDA
13/05/2026
Q1 2026 Positive Adjusted EBITDA (1) Net Revenue of $9M with strong gross margins of 37% OPEX decreased 28% in Q1 2026 versus Q4 2025 Company is virtually debt free, with a Q1 ending cash balance of $9.9 million and [...]
PolyPid Provides Corporate Update and Reports First Quarter 2026 Financial Results
13/05/2026
Initiated NDA Submission to the FDA for D-PLEX₁₀₀ ; Completion Expected Imminently U.S. Commercial Partnership Discussions in Late Stages Conference Call Scheduled for Today at 8:30 AM ET PETACH TIKVA, Israel, May 13, [...]
Kane Biotech Presents Data To Global Wound Care Community at WCET®–NSWOCC® 2026 Joint Congress
13/05/2026
Case study presented highlighted clinical experience with revyve® in complex wound care WINNIPEG, Manitoba, May 13, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) [...]
Altimmune to Present Results of Pemvidutide in MASH in an Oral Presentation and Multiple Poster Presentations at EASL Congress 2026
13/05/2026
Abstract presenting 48-week IMPACT Phase 2b efficacy and safety data selected for inclusion in “Best of EASL 2026” by EASL Oral presentation will highlight further the 48-week IMPACT efficacy and safety data Late- [...]
Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Update
13/05/2026
CARDAMYST™ (etripamil) nasal spray launch for PSVT is gaining traction ; breadth of unique prescribers supports potential future adoption Express Scripts national formulary coverage secured as company makes progress [...]
Ocugen to Participate in Upcoming May Scientific and Investor Conferences
13/05/2026
MALVERN, Pa., May 13, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the Company will [...]
Andera Partners Leads $20 Million Series D Financing in Rivermark Medical
13/05/2026
The FloStent™ System Promises to Redefine the BPH Care Pathway Paris, France, and Milwaukee, WI, US, May 13, 2026 (GLOBE NEWSWIRE) -- Andera Partners, a leading European venture capital and private equity firm, today [...]
Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences
13/05/2026
NORWOOD, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP), a clinical-stage company focused on developing promising new therapies in oncology and obesity, today announced that [...]
Nurix Therapeutics to Participate in Upcoming Investor Conferences
13/05/2026
BRISBANE, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein [...]
Humacyte Announces First Quarter 2026 Financial Results and Provides Business Update
13/05/2026
- Appointed Jim Mercadante as Chief Commercial Officer and Dr. Todd Rasmussen as Chief Surgical Officer - - First quarter sales of Symvess® were $0.5 million in 2026 compared to $0.1 million in 2025 - - Purchase [...]
Opus Genetics to Present at the RBC Capital Markets 2026 Global Healthcare Conference
13/05/2026
RESEARCH TRIANGLE PARK, N.C., May 13, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision [...]
Verano Submits DEA Registration Applications for State-Licensed Medical Cannabis Businesses Following Landmark Federal Rescheduling Order
13/05/2026
CHICAGO, May 13, 2026 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNO) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced the Company has submitted applications [...]
BioCryst to Present New Real-World Evidence Underscoring the Ongoing Burden of Pediatric Hereditary Angioedema at ISPOR 2026
13/05/2026
RESEARCH TRIANGLE PARK, N.C., May 13, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present new real-world evidence at the 2026 International Society for [...]
Atea Pharmaceuticals to Present Three Abstracts at EASL 2026 Congress Highlighting Progress Across Viral Hepatitis Pipeline
13/05/2026
BOSTON, May 13, 2026 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a late-stage clinical biopharmaceutical company engaged in the discovery and development of oral antiviral [...]
PDS Biotech Reports First Quarter 2026 Financial Results and Provides Clinical Programs and Corporate Update
13/05/2026
Investor Webcast Scheduled for 8:00 am ET PRINCETON, N.J., May 13, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on [...]
Avalo Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Updates
13/05/2026
Achieved positive topline results in Phase 2 LOTUS trial of abdakibart in moderate to severe hidradenitis suppurativa (HS) and plan to advance into a registrational phase 3 program Completed public offering of equity [...]
BeyondSpring Reports First-Quarter 2026 Financial Results and Provides Corporate Update
13/05/2026
AACR 2026 Data Positions Plinabulin as a Potential Backbone Agent to Combine with Antibody-Drug Conjugate (ADC)-Based Therapies to Improve Anti-Cancer Efficacy and Tolerability SEED Advances First Molecular Glue [...]
Seer Files Patent Infringement Lawsuit Against Nanomics
13/05/2026
Seer defends its pioneering Proteograph ® Product Suite intellectual property (IP) REDWOOD CITY, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a pioneer and trusted partner for deep, unbiased [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum